Proliferative vitreoretinopathy: risk factors and pathobiology.
about
Calpain-5 mutations cause autoimmune uveitis, retinal neovascularization, and photoreceptor degenerationClassifications for Proliferative Vitreoretinopathy (PVR): An Analysis of Their Use in Publications over the Last 15 YearsAn ocular view of the IGF-IGFBP systemPersonalized Medicine in Ocular Fibrosis: Myth or Future BiomarkersProliferative vitreoretinopathy: current and emerging treatmentsInhibition of the TGFβ Pathway Enhances Retinal Regeneration in Adult ZebrafishLGR4 Is a Direct Target of MicroRNA-34a and Modulates the Proliferation and Migration of Retinal Pigment Epithelial ARPE-19 CellsIntraocular expression and release of high-mobility group box 1 protein in retinal detachmentSelective activation of p120ctn-Kaiso signaling to unlock contact inhibition of ARPE-19 cells without epithelial-mesenchymal transitionThe effect of a preoperative subconjuntival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial.The complex interplay between ERK1/2, TGFβ/Smad, and Jagged/Notch signaling pathways in the regulation of epithelial-mesenchymal transition in retinal pigment epithelium cells.Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy.Interleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control study.Snail involves in the transforming growth factor β1-mediated epithelial-mesenchymal transition of retinal pigment epithelial cellsEnhanced PKCδ and ERK signaling mediate cell migration of retinal pigment epithelial cells synergistically induced by HGF and EGF.Involvement of RhoA/ROCK1 signaling pathway in hyperglycemia-induced microvascular endothelial dysfunction in diabetic retinopathyInhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and MAPK pathways.The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.Expression of pigment epithelium-derived factor and thrombospondin-1 regulate proliferation and migration of retinal pigment epithelial cells.Protein changes in the retina following experimental retinal detachment in rabbits.Surgical outcomes for primary rhegmatogenous retinal detachments in patients with pseudophakia after phacoemulsification.Aqueous and alcoholic extracts of Triphala and their active compounds chebulagic acid and chebulinic acid prevented epithelial to mesenchymal transition in retinal pigment epithelial cells, by inhibiting SMAD-3 phosphorylation.Protein tyrosine phosphatase 1B regulates the activity of retinal pigment epithelial cellsOcular pathogenesis and immune reaction after intravitreal dispase injection in mice.Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19.Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative VitreoretinopathyAssessment of the innate and adaptive immune system in proliferative vitreoretinopathy.Upregulation of Mir-21 Levels in the Vitreous Humor Is Associated with Development of Proliferative Vitreoretinal Disease.Validity of aqueous flare measurement in predicting proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment.Auranofin Inhibits Retinal Pigment Epithelium Cell Survival through Reactive Oxygen Species-Dependent Epidermal Growth Factor Receptor/ Mitogen-Activated Protein Kinase Signaling PathwayTroglitazone suppresses transforming growth factor beta-mediated fibrogenesis in retinal pigment epithelial cells.A novel coculture model of porcine central neuroretina explants and retinal pigment epithelium cells.Scleral buckling surgery for rhegmatogenous retinal detachment with subretinal proliferationThe inhibitory effect of small interference RNA protein kinase C-alpha on the experimental proliferative vitreoretinopathy induced by dispase in mice.Vitreous induces heme oxygenase-1 expression mediated by transforming growth factor-beta and reactive oxygen species generation in human retinal pigment epithelial cellsAdalimumab (tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina.Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins.The genomic response of the retinal pigment epithelium to light damage and retinal detachment.Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
P2860
Q24300646-773CB282-B840-4A41-8D66-A38930F55942Q26739751-73FD46A6-947D-43FF-A112-87A1836938FFQ27013698-AF32E9AF-952A-4AF9-9803-39EEFB921F88Q28079275-FDCD7046-8D47-4888-8E47-39394E32CEE3Q28274083-553D6BDC-9D56-4977-BECB-12F137E66EB1Q28553695-DD9FBE8C-5B90-4EBB-B890-DE4F7E2B5CE3Q28555052-75416687-8BA0-4AC5-9A88-85F930047DFDQ28574646-00057405-A29B-4207-B3D0-627C3ED0A4D5Q28730053-1BB37678-1021-4E2E-8818-A624B19F46E4Q33534181-5DE3720A-C508-4A69-8405-064CBE03DF9AQ33560424-5EC8D9F5-B602-4B37-A910-99C948C837BDQ33595120-D9DF29BC-692B-4813-9FEE-E7AF774DB4B1Q33893886-0EB7F851-5231-40F1-B992-6C4AD582034FQ33997079-08FC07FA-0AA9-4AEA-84BD-9E42AC2D8F85Q34427717-EDF48237-0DE4-4026-AAFB-9629303C736CQ34501845-51539399-F318-4B61-B26B-023844081004Q34607101-9A0BD2ED-D6C2-4506-AF8B-9EB941A77AD7Q35070151-43ADF74D-1B83-4318-847A-260186F1843FQ35294211-4C58F9E3-6072-43AC-8C66-E87499ECED36Q35531768-B7C68A13-8AC8-4FBB-A91E-0F4DE10378DAQ35572123-A87BD343-6C0B-4BCC-969B-B07620E62FAFQ35582614-C89AA6FE-AFA7-4888-B483-4064976CAEE7Q35605633-98E43B25-B4F5-4578-92BA-78A918890D81Q35891559-E3596CE4-BF92-4389-9671-8B879F266847Q35919077-522C052D-2E3A-4F07-8FE2-7D2F781BBA8EQ36008844-8C4EDD0B-960D-4E02-B2B4-E60F1BA38F2EQ36035808-F6ABE7B0-FC4B-431B-A90F-F70D8FB85BDFQ36063043-554F8CC7-4E46-4AEA-BD45-84A1BF78C266Q36147426-1B67AF77-5235-4541-AE14-DBB1DE44E200Q36192986-14ECF3E7-791C-4F68-B519-8E41A7551967Q36478992-B17CF571-5F4C-4E44-80D9-3018EE43C54CQ36742061-6AD29CE2-7DC2-405F-8BB7-49160E50AC6DQ36752270-BB0FC834-11AD-4C3B-93C9-83B6D3461B75Q36785089-2482DD42-E0DD-4575-86FD-78E458734A54Q36822065-FD0ABFF4-2497-4BD0-B80F-2A9A5EED80DAQ36846629-A72D5AE6-2A20-4D4D-91C9-1622C46C5D0AQ36906404-1F3F790D-82DD-4E7D-8DD9-6B514D3DDB5CQ36944774-29CD7855-AA1E-484A-ABCF-8648EE099B77Q36970828-50DA08EB-C5F7-4430-AD98-1579CE565BAFQ37023057-C2AB47A4-BCB0-4063-AC7B-C0B77C49E78D
P2860
Proliferative vitreoretinopathy: risk factors and pathobiology.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Proliferative vitreoretinopathy: risk factors and pathobiology.
@ast
Proliferative vitreoretinopathy: risk factors and pathobiology.
@en
Proliferative vitreoretinopathy: risk factors and pathobiology.
@nl
type
label
Proliferative vitreoretinopathy: risk factors and pathobiology.
@ast
Proliferative vitreoretinopathy: risk factors and pathobiology.
@en
Proliferative vitreoretinopathy: risk factors and pathobiology.
@nl
prefLabel
Proliferative vitreoretinopathy: risk factors and pathobiology.
@ast
Proliferative vitreoretinopathy: risk factors and pathobiology.
@en
Proliferative vitreoretinopathy: risk factors and pathobiology.
@nl
P2093
P1476
Proliferative vitreoretinopathy: risk factors and pathobiology.
@en
P2093
E Rodríguez de la Rúa
Francisco Martín
J Carlos Pastor
P304
P356
10.1016/S1350-9462(01)00023-4
P577
2002-01-01T00:00:00Z